Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1213
1144. YOKOZAWA T, FUJITSUKA N, AND OURA H. Studies on the
precursor of methylguanidine in rats with renal failure. Nephron
58: 90–94, 1991.
1145. YOKOZAWA T, FUJITSUKA N, AND OURA H. Variations in the
distribution of methylguanidine with the progression of renal
failure after methylguanidine loading. Nephron 52: 347–351, 1989.
1146. YOKOZAWA T, FUJITSUKA N, OURA H, IENAGA K, AND NA-
KAMURA K. In vivo effect of hydroxyl radical scavenger on
methylguanidine production from creatinine. Nephron 75: 103–
105, 1997.
1147. YOKOZAWA T, MO ZL, AND OURA H. Comparison of toxic effects
of methylguanidine, guanidinosuccinic acid and creatinine in rats
with adenine-induced chronic renal failure. Nephron 51: 388–392,
1989.
1148. YOKOZAWA T, OURA H, IENAGA K, AND NAKAMURA K. Comparison
of renal effects of creatinine, creatol and methylguanidine
in rats with adenine-induced chronic renal failure. Nephron 64:
424–428, 1993.
1149. YOKOZAWA T, OURA H, IENAGA K, AND NAKAMURA K. Effects
of creatinine, creatol and methylguanidine on renal function. Jpn
J Nephrol 34: 973–977, 1992.
1150. YORIFUJI T, SHIRITANI Y, EGUCHI S, AND YONAHA K. Taurocyamine-utilizing
mutants from a wild-type strain of Pseudomonas.
J Appl Biochem 5: 375–381, 1983.
1151. YORIFUJI T, TAMAI H, AND USAMI H. Purification, crystallization
and properties of Mn 2� dependent guanidinoacetate amidinohydrolase
from a Pseudomonas. Agric Biol Chem 41: 959–
966, 1977.
1152. YOSHIMOTO T, OKA I, AND TSURU D. Creatine amidinohydrolase
of Pseudomonas putida: crystallization and some properties.
Arch Biochem Biophys 177: 508–515, 1976.
1153. YOUNG RB AND DENOME RM. Effect of creatine on contents of
myosin heavy chain and myosin-heavy-chain mRNA in steadystate
chicken muscle-cell cultures. Biochem J 218: 871–876,
1984.
1154. YUAN G, KANEKO M, MASUDA H, HON RB, KOBAYASHI A, AND
YAMAZAKI N. Decrease in heart mitochondrial creatine kinase
activity due to oxygen free radicals. Biochim Biophys Acta 1140:
78–84, 1992.
1155. ZAHLER R AND INGWALL JS. Estimation of heart mitochondrial
creatine kinase flux using magnetization transfer NMR
spectroscopy. Am J Physiol Heart Circ Physiol 262: H1022–
H1028, 1992.
1156. ZAJC A, ROMÃO MJ, TURK B, AND HUBER R. Crystallographic
and fluorescence studies of ligand binding to N-carbamoylsarcosine
amidohydrolase from Arthrobacter sp. J Mol Biol 263:
269–283, 1996.
1157. ZARGHAMI N, GIAI M, YU H, ROAGNA R, PONZONE R, KATSA-
ROS D, SISMONDI P, AND DIAMANDIS EP. Creatine kinase BB
isoenzyme levels in tumour cytosols and survival of breast cancer
patients. Br J Cancer 73: 386–390, 1996.
1158. ZEMTSOV A, CAMERON GS, STADIG B, AND MARTIN J. Measurement
of phosphocreatine in cutaneous tissue by high pressure
liquid chromatography. Am J Med Sci 305: 8–11, 1993.
1159. ZHANG J, MERKLE H, HENDRICH K, GARWOOD M, FROM AHL,
UGURBIL K, AND BACHE RJ. Bioenergetic abnormalities associated
with severe left ventricular hypertrophy. J Clin Invest 92:
993–1003, 1993.
1160. ZHANG L-H AND JENSSEN D. Site specificity of N-methyl-N-nitrosourea-induced
transition mutations in the hprt gene. Carcinogenesis
12: 1903–1909, 1991.
1161. ZHAO J, SCHMIEG FI, SIMMONS DT, AND MOLLOY GR. Mouse
p53 represses the rat brain creatine kinase gene but activates the
rat muscle creatine kinase gene. Mol Cell Biol 14: 8483–8492, 1994.
1162. ZHOU G, SOMASUNDARAM T, BLANC E, PARTHASARATHY G,
ELLINGTON WR, AND CHAPMAN MS. Transition state structure
of arginine kinase: implications for catalysis of bimolecular reactions.
Proc Natl Acad Sci USA 95: 8449–8454, 1998.
1163. ZWEIER JL, JACOBUS WE, KORECKY B, AND BRANDEJS-BARRY
Y. Bioenergetic consequences of cardiac phosphocreatine depletion
induced by creatine analogue feeding. J Biol Chem 266:
20296–20304, 1991.